ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

NIH Grants: R29 Awards No Longer Accepted After June; NIH To Increase R01s.

December 5, 1997

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions

November 4, 1983